Immuneering Corporation
IMRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $65,959 | $208,862 | $127,976 | $425,598 |
| - Cash | $36,145 | $59,406 | $72,637 | $74,888 |
| + Debt | $4,163 | $4,463 | $4,842 | $5,365 |
| Enterprise Value | $33,977 | $153,919 | $60,181 | $356,074 |
| Revenue | $0 | $0 | $317 | $2,080 |
| % Growth | – | -100% | -84.8% | – |
| Gross Profit | $0 | $0 | $159 | $927 |
| % Margin | – | – | 50.1% | 44.6% |
| EBITDA | -$63,687 | -$58,061 | -$51,468 | -$33,727 |
| % Margin | – | – | -16,238.4% | -1,621.5% |
| Net Income | -$61,037 | -$53,472 | -$50,514 | -$33,536 |
| % Margin | – | – | -15,937.3% | -1,612.3% |
| EPS Diluted | -2.04 | -1.88 | -1.87 | -1.27 |
| % Growth | -8.5% | -0.5% | -47.2% | – |
| Operating Cash Flow | -$55,000 | -$48,969 | -$44,101 | -$30,851 |
| Capital Expenditures | -$85 | -$343 | -$742 | -$61 |
| Free Cash Flow | -$55,084 | -$49,311 | -$44,844 | -$30,912 |